JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M303403200 on June 4, 2003

J. Biol. Chem., Vol. 278, Issue 33, 30705-30710, August 15, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/33/30705    most recent
M303403200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, B.
Right arrow Articles by Tse-Dinh, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, B.
Right arrow Articles by Tse-Dinh, Y.-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Direct Interaction between Escherichia coli RNA Polymerase and the Zinc Ribbon Domains of DNA Topoisomerase I*

Bokun Cheng, Chang-Xi Zhu, Chengling Ji {ddagger}, Adriana Ahumada § and Yuk-Ching Tse-Dinh 

From the Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, New York 10595

Received for publication, April 2, 2003 , and in revised form, May 29, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Escherichia coli DNA topoisomerase I (encoded by the topA gene) is important for maintaining steady-state DNA supercoiling and has been shown to influence vital cellular processes including transcription. Topoisomerase I activity is also needed to remove hypernegative supercoiling generated on the DNA template by the progressing RNA polymerase complex during transcription elongation. The accumulation of hypernegative supercoiling in the absence of topoisomerase I can lead to R-loop formation by the nascent transcript and template strand, leading to suppression of transcription elongation. Here we show by affinity chromatography and overlay blotting that E. coli DNA topoisomerase I interacts directly with the RNA polymerase complex. The protein-protein interaction involves the {beta}' subunit of RNA polymerase and the C-terminal domains of E. coli DNA topoisomerase I, which are homologous to the zinc ribbon domains in a number of transcription factors. This direct interaction can bring the topoisomerase I relaxing activity to the site of transcription where its activity is needed. The zinc ribbon C-terminal domains of other type IA topoisomerases, including mammalian topoisomerase III, may also help link the enzyme activities to their physiological functions, potentially including replication, transcription, recombination, and repair.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
DNA topoisomerases are ubiquitous enzymes that have functional roles in many vital cellular processes (1, 2). Among different classes of topoisomerases, type IA topoisomerases found in archea, prokaryotes, and eukaryotes share the mechanistic feature of cutting and rejoining a single strand of DNA via a 5'-phosphotyrosine linkage and homologous amino acid sequences (3). Escherichia coli DNA topoisomerase I (encoded by the topA gene) is the most extensively studied example of this class of enzyme. Its most apparent physiological role is the maintenance of steady-state DNA supercoiling (4, 5). During transcription, the movement of the RNA polymerase complex on the DNA template creates local transcription-driven supercoiling with negative supercoiling generated behind the RNA polymerase and positive supercoiling generated ahead of the RNA polymerase (6, 7). DNA gyrase is needed for removing the positive supercoils, and topoisomerase I is responsible for removing the excess negative supercoils. In the absence of topoisomerase I function due to mutation in the topA gene, the accumulation of hypernegative supercoiling can lead to R-loop formation by nascent transcription and template stranding with the consequent suppression of transcription elongation (8, 9).

In previous studies, Tn5 transposase was found to copurify with E. coli DNA topoisomerase I and inhibit the topoisomerase I activity (10). RNA polymerase was also found to copurify with Tn5 transposase, but the copurification was reduced in extracts from a topA mutant strain, suggesting that the interaction between RNA polymerase and DNA topoisomerase I was responsible for the copurification of RNA polymerase with Tn5 transposase (10). The proposed function of topoisomerase I activity in removal of transcription-driven hypernegative supercoiling (8, 9) would be greatly facilitated by direct protein-protein interaction with RNA polymerase. Experiments described here provide direct evidence for such interaction as well as identifying the domain of topoisomerase I and the subunit in RNA polymerase that are responsible for this protein-protein interaction.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Enzymes—E. coli DNA topoisomerase I and its subdomains were expressed and purified as described previously (1114). Purified E. coli RNA polymerase was purchased from Epicentre and USB Corp.

Maltose-binding Protein Affinity Chromatography—A PCR fragment encoding the E. coli topA gene was generated by Pfu DNA polymerase (from Stratagene) and cloned into the XmnI site of pMal-c2X (New England BioLabs) to create a fusion protein with MBP1 linked to the N terminus of topoisomerase I. Expression of MBP-topoisomerase I and MBP in E. coli TB1 cells was induced with isopropyl-1-thio-{beta}-D-galactopyranoside. Cells from a 250-ml culture were lysed by lysozyme treatment combined with freeze-thawing in phosphate-buffered saline. The soluble extract obtained after centrifugation was applied to 1 ml of amylose resin (New England BioLabs) equilibrated with column buffer (20 mM Tris, pH 7.5, 200 mM NaCl, 1 mM EDTA). After extensive washing, the proteins bound to the column were eluted with column buffer containing 10 mM maltose.

RNA Polymerase Affinity Chromatography—Polyol-responsive monoclonal antibodies against E. coli RNA polymerase {beta}' subunit (NT73) was purchased from Neoclones and coupled to cyanogen bromide-activated Sepharose according to published procedures using 0.9 ml of the antibodies (15). The NT73 affinity matrix was mixed with 1 ml of extracts of E. coli BL21 cells prepared from 400 ml of culture expressing intact topoisomerase I (11) or its subdomains (1214) as described for affinity purification of RNA polymerase (15). After extensive washing, the bound proteins were eluted with 1 ml of 40% ethylene glycol with 0.75 M NaCl.

Blotting of RNA Polymerase with Digoxigenin (DIG)-labeled Topoisomerase I and Its Subdomains—Purified RNA polymerase (0.8 µg) was electrophoresed in SDS-polyacrylamide gel to separate the subunits. The proteins were transferred onto either supported nitrocellulose membrane for chemiluminescence detection or polyvinylidene difluoride membrane for color detection. Topoisomerase I and its subdomains were labeled with DIG using the labeling kit from Roche Applied Science. Each DIG-labeled protein was incubated with the membrane at 25 °C for 1 h. Anti-DIG antibodies linked to peroxidase were used for detection by the ECL Plus system (Amersham Biosciences). Anti-DIG antibodies linked to alkaline phosphatase were used for color detection with the nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate substrate (Roche Applied Sciences). After color detection, the position of the topoisomerase I-binding signal was marked and photographed before staining of the nylon membrane by Coomassie Blue.

In Vitro Transcription—In vitro transcription with E. coli RNA polymerase (3 units) was carried out with procedures similar to those described previously (16). The reaction (30 µl) contained 40 mM Hepes/KOH (pH 7.6), 11 mM magnesium acetate, 100 mM potassium glutamate, 1 mM dithiothreitol, 4 mM ATP, 0.5 mM each of GTP, CTP, and UTP, 0.5 µg of negatively supercoiled plasmid pBR322. Transcription was carried out at 37 °C for 10 min. After deproteinization by phenol extraction, the DNA samples were analyzed by electrophoresis in 1% agarose gel with 0.5x TPE (90 mM Tris, 90 mM phosphate, 2 mM EDTA, pH 8.0) buffer with the indicated chloroquine concentrations for detection of positively supercoiled DNA (17). One-dimensional agarose gels were stained with ethidium bromide and photographed. When analyzed by two-dimensional agarose gel electrophoresis, DNA was visualized by hybridization to 32P-labeled probes as described previously (17).

Induction of Synthesis of the 14-kDa C-terminal Fragment in Vivo— DNA coding for the 14-kDa C-terminal fragment of E. coli DNA topoisomerase I was generated by PCR using the Pfu DNA polymerase and inserted into the pBADThio-TOPO expression vector (from Invitrogen). The resulting plasmid pBAD14K has the 14-kDa C-terminal fragment fused to the carboxyl end of thioredoxin and under the control of pBAD promoter. E. coli strain TOP10 with wild-type topoisomerase genotypes (from Invitrogen) was transformed with either pBAD14K or the control plasmid pBAD/Thio expressing thioredoxin. Cells were grown at 37 °C in LB containing 100 µg/ml ampicillin until A600 reached 0.5, when transcription from the PBAD promoter was induced by addition of 0.005% arabinose. Cell growth was continued for 4 h at 37 °C before harvest of the cell pellets for plasmid preparation using the Qiagen kit. Plasmid DNA supercoiling was analyzed by two-dimensional gel electrophoresis using chloroquine concentrations specific for identification of hypernegatively supercoiled DNA (16, 17) and was visualized by hybridization to a 32P-labeled probe and by autoradiography.

Survival Rates after N-Ethylmaleimide (NEM) Treatment—RFM445 (gyrB22(couR)gyrB203(Ts)), RFM475 (gyrB22(couR)gyrB203(Ts), and {Delta}(topAcysB)) and its transformants were cultured in LB broth at 37 °C to stationary phase (>18 h). Plasmid pJW312 (18) was used for expression of full-length topoisomerase I, whereas its linker insertion derivative pJW2277ter (18) was used for expressing Top85 lacking the 14-kDa C-terminal fragment (19). Plasmid for expression of Top67 lacking the 30-kDa terminal fragment was constructed by introduction of a termination codon in pJW312 via site-directed mutagenesis (14). The cells were washed and resuspended in M9 medium as described (20) before treatment for 1 h with 8 mM NEM at 37 °C. The rate of survival was determined by serial dilutions and plating of treated cells as well as control cells not treated with NEM. Colonies on LB plates were counted after 36 h of incubation at 37 °C.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Direct Interaction between E. coli DNA Topoisomerase I and RNA Polymerase—Extract of E. coli cells expressing recombinant E. coli DNA topoisomerase I with MBP fused to its N-terminal end was applied to amylose resin. The bound topoisomerase I and any associated cellular proteins were then eluted with buffer containing maltose. Identical procedures were carried out with elution of recombinant MBP from amylose resin. When the maltose eluate fractions were analyzed by Western blotting, RNA polymerase {alpha} and {beta}' subunits were detected in the eluate fractions from cells expressing MBP-topoisomerase I but not in the eluate fractions prepared from cells expressing MBP (Fig. 1). This demonstrates that the linkage of DNA topoisomerase I to MBP is required for binding of RNA polymerase to the amylose resin.



View larger version (38K):
[in this window]
[in a new window]
 
FIG. 1.
Binding of RNA polymerase to MBP-topoisomerase I (MBP-TOPO) retained on the amylose resin. MBP (lane 1) or MBP-topoisomerase I (lane 2) retained on the amylose resin was eluted with column buffer + 10 mM maltose. a, the eluted proteins were stained with Coomassie Blue after SDS-gel electrophoresis. b, the eluted proteins were analyzed by Western blot using monoclonal antibodies against E. coli RNA polymerase {alpha} and {beta}' subunits.

 

The Zinc Ribbon Domains of Topoisomerase I Are Responsible for the Interaction with RNA Polymerase—An RNA polymerase affinity column was prepared using polyol-responsive monoclonal antibodies against the {beta}' subunit of E. coli RNA polymerase (15). Soluble extracts of E. coli BL21 cells expressing DNA topoisomerase I (11) or its subdomains (1214) were applied individually to the affinity column in separate experiments carried out with identical procedures (Fig. 2). Topoisomerase I could be detected in the bound proteins eluted from this affinity column with buffer containing 40% ethylene glycol and 0.75 M NaCl. In similar experiments carried out separately with lysates expressing an individual topoisomerase I subdomain, it was determined that the 67-kDa N-terminal transesterification domain (Top67) did not bind to the affinity column but the 20-kDa (ZD2) and 14-kDa C-terminal fragments could bind to the RNA polymerase affinity column. These two fragments contain three and two copies of zinc ribbon domains, respectively, and are homologous to the zinc ribbon domains in transcription regulators including RPB9, TFIIS, and TFIIB (21). However, only the three zinc ribbon domains on ZD2 have Zn(II) bound to tetracysteine motifs (13). Binding of the RNA polymerase subunits to this affinity column was confirmed by both Coomassie Blue staining of the eluted proteins and Western blot analysis using antibodies against the {alpha}, {beta}, and {beta}' subunits (Fig. 2c).



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 2.
Binding of topoisomerase I and its subdomains to RNA polymerase (RNAP) affinity column prepared with monoclonal antibody to the {beta}' subunit. a, presence of topoisomerase I or its 14-kDa C-terminal fragment in the eluate from the column was detected by Western blot with rabbit polyclonal antibodies against topoisomerase I in two separate experiments. b, capability of the different subdomains of topoisomerase I in binding to the RNA polymerase affinity column was determined in separate experiments with the procedures described above. Tyr, position of active site tyrosine. c, binding of the RNA polymerase subunits to the affinity column demonstrated by Coomassie Blue staining and Western blot. Extract of cells expressing the 14-kDa fragment (*) was applied to the affinity matrix. M, molecular mass standards; I, input lysate (2 µl); W, final wash fraction (20 µl); E, eluate (20 µl). For Coomassie Blue staining, the entire eluate was concentrated and applied to the gel to visualize the eluted proteins.

 

The {beta}' Subunit of RNA Polymerase Interacts with Topoisomerase I—E. coli RNA polymerase was expected to bind to the affinity matrix as a multisubunit complex. To determine which subunit was responsible for the interaction with DNA topoisomerase I, the RNA polymerase subunits were electrophoresed in a 7% SDS-polyacrylamide gel and transferred onto membrane. Overlay blotting was carried out using DIG-labeled topoisomerase I, DIG-labeled Top67, DIG-labeled ZD2, and DIG-labeled 14-kDa fragment. All of these DIG-labeled proteins, except DIG-labeled Top67, gave a positive chemiluminescence signal with peroxidase-linked anti-DIG antibody at a position where RNA polymerase {beta} and {beta}' subunits would migrate in the 7% SDS-polyacrylamide gel (Fig. 3a). This result was in agreement with the data in Fig. 2b and showed that DNA that might have been present in the E. coli protein extract during binding to the affinity columns was not required for interaction between DNA topoisomerase I and RNA polymerase. There was also no signal when the RNA polymerase subunits on the membrane were blotted with DIG-labeled bovine serum albumen.



View larger version (59K):
[in this window]
[in a new window]
 
FIG. 3.
Interaction of DIG-topoisomerase I, DIG-ZD2, and DIG-14-kDa fragment with the {beta}' subunit of RNA polymerase on membrane. a, overlay blotting of RNA polymerase subunits with DIG-topoisomerase I, DIG-Top67, DIG-ZD2 and DIG-14 kDa detected by chemiluminescence using peroxidase-linked anti-DIG antibody. The positions of {alpha}, {beta}, and {beta}' subunits electrophoresed in different lanes on the same 7% SDS-polyacrylamide gel were visualized with Western blots using monoclonal antibodies against those subunits. DIG-labeled bovine serum albumen was used as a negative control for the overlay. b, binding of DIG-ZD2 and DIG-14-kDa fragment to RNA polymerase subunits separated on a 5% SDS-polyacrylamide gel was first visualized with alkaline phosphatase-linked anti-DIG antibody and color substrate. After the position of the DIG signal was recorded, the membrane was then stained with Coomassie Blue to visualize both {beta} and {beta}' in the same lane. Blotting with DIG-topoisomerase I according to this procedure gave the same results.

 

To determine whether the {beta} or {beta}' subunit was interacting with topoisomerase I, a 5% polyacrylamide gel was used for SDS-gel electrophoresis of the RNA polymerase subunits to better separate these two high molecular weight subunits. After transfer, the membrane was incubated with DIG-labeled ZD2 followed by alkaline-phosphatase linked anti-DIG antibodies. The signal of the DIG-topoisomerase I fragment bound to the nylon membrane was developed with the nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate color reagent. The position of the signal was marked on the membrane and photographed alongside a ruler. The nylon membrane was then stained with Coomassie Blue to visualize both the {beta} and {beta}' subunits in the gel lane analyzed previously with the alkaline-phosphatase linked anti-DIG antibodies. A comparison with the previously marked and photographed signal from alkaline phosphatase indicated that the topoisomerase I subdomain was interacting with the {beta}' subunit (Fig. 3b). The experiment was repeated using DIG-topoisomerase I or DIG 14-kDa fragment, and both of these also interacted with the {beta}' subunit (Fig. 3b and data not shown).

Direct Interaction between E. coli RNA Polymerase and Topoisomerase I Is Important for Removal of Transcription-driven Negative Supercoils—It has been proposed that topoisomerase I plays an important physiological role in the removal of negative supercoils formed during transcription because of the movement of the RNA polymerase complex (69). In an in vitro transcription reaction in the presence of DNA topoisomerase I, positive supercoiling of the DNA template results from the removal of transcription-driven negative supercoils by topoisomerase I (7, 16). To demonstrate that the direct interaction between E. coli RNA polymerase and topoisomerase I is important for the removal of transcription-driven negative supercoils, a recombinant 14-kDa C-terminal fragment (purified from an overexpression system (12) at >99% purity as determined by Coomassie Blue staining of SDS gel (data not shown)) was also added to the in vitro transcription reaction. The 14-kDa C-terminal fragment could compete with topoisomerase I for interaction with E. coli RNA polymerase, and the formation of positively supercoiled DNA template was found to be inhibited (Fig. 4). In a relaxation reaction in the absence of RNA polymerase, the 14-kDa fragment has no significant effect on the relaxation of negatively supercoiled DNA by DNA topoisomerase I; thus so the 14-kDa fragment does not inhibit the catalytic activity of DNA topoisomerase I (Fig. 4c).



View larger version (28K):
[in this window]
[in a new window]
 
FIG. 4.
Effect of competing 14-kDa C-terminal fragment on the removal of transcription-driven negative supercoils by topoisomerase I and subsequent accumulation of positive supercoils. a, plasmid pBR322 DNA template was analyzed after in vitro transcription reaction by gel electrophoresis in the presence of 4 µM chloroquine (16). Lane 1, transcription reaction with RNA polymerase only (RNAP); lane 2, with 2 µM 14-kDa fragment; lane 3, with 40 nM topoisomerase I; lane 4, with topoisomerase I and 14-kDa fragment. b, plasmid DNA template from lanes 3 and 4 in panel A were analyzed by two-dimensional gel electrophoresis with 0.5x TPE buffer with no chloroquine in the first dimension and 15 µM chloroquine added in the second dimension (17). c, the 14-kDa C-terminal fragment did not inhibit the relaxation activity of DNA topoisomerase I. 0.5 µg of negatively supercoiled plasmid DNA was relaxed by DNA topoisomerase I for 30 min at 37 °C under standard topoisomerase I assay conditions (37) in the presence of an increasing amount of 14-kDa fragment. Lane 1, control, no topoisomerase added; lane 2, with 32 nM topoisomerase I; lanes 3–5, with topoisomerase I and 0.4, 0.8, and 1.6 µM 14-kDa fragment. Agarose gel electrophoresis was carried out in Tris acetate EDTA buffer.

 

The significance of the RNA polymerase-topoisomerase I interaction for removal of transcription driven supercoils was also demonstrated in vivo. The 14-kDa C-terminal domain was expressed in E. coli as a thioredoxin fusion protein via the tightly regulated PBAD promoter (22). Accumulation of hypernegative supercoils in the plasmid DNA was observed when synthesis of the 14-kDa C-terminal fragment by pBAD14K was induced by addition of 0.005% arabinose to the culture (Fig. 5a). The induced 14-kDa C-terminal domain was expected to compete with topoisomerase I for interaction with RNA polymerase, impeding the removal of transcription-driven negative supercoils by DNA topoisomerase I. The level of 14-kDa C-terminal domain synthesis and resulting accumulation of hypernegatively supercoiled DNA did not vary significantly when the arabinose concentration was varied between 0.001 and 0.1% (data not shown). Induction of expression of thioredoxin in the control pBAD/THIO plasmid under the same experimental conditions did not result in accumulation of hypernegatively supercoiled DNA (Fig. 5b).



View larger version (48K):
[in this window]
[in a new window]
 
FIG. 5.
Accumulation of hypernegatively supercoiled DNA upon induction of thioredoxin-14-kDa C-terminal fragment fusion protein. Plasmid DNA pBAD14K (a) and pBAD/THIO (b) extracted from noninduced or 0.005% arabinose-induced cultures were analyzed by two-dimensional agarose gel electrophoresis in 0.5x TPE buffer with 15 µM chloroquine in the first dimension and 60 µM chloroquine in the second dimension (24). – –, hypernegatively supercoiled DNA.

 

Zinc Ribbons Are Important for in Vivo Function of Topoisomerase I during Stress Response—An 85-kDa truncated topoisomerase I lacking the 14-kDa C-terminal fragment (Top85) has been shown previously to be active in relaxation of supercoiled DNA (18, 19). The in vitro relaxing activity of Top85 was >75% of that of the full-length enzyme, albeit with lower processivity in high salt (19). In vivo, Top85 could fully complement the viability of the E. coli strain AS17 that has a temperature-sensitive topoisomerase I (18, 23). Top85 has three of the five zinc ribbon domains present in topoisomerase I. We hypothesize that during stress response, when rapid transcription of induced genes takes place, direct interaction between topoisomerase I and RNA polymerase via the zinc ribbon domains may be important for survival. We have previously shown that the E. coli strain RFM475 with the topA gene deleted is much more sensitive to killing by the toxic electrophile NEM than the isogenic topA+ strain RFM445 (20). The increased sensitivity of RFM475 to NEM can be reversed by the presence of a plasmid expressing DNA topoisomerase I (20). Strain RFM475 was transformed with plasmids expressing full-length topoisomerase I or its truncated forms lacking the C-terminal fragments. Comparison of the survival rates of the RFM475 transformants after NEM treatment (Fig. 6) showed that the survival rate of the transformant expressing Top85 was higher than the transformant expressing Top67 but still about 100-fold lower than that of the transformant expressing the full-length topoisomerase I. Although not required for viability of E. coli under optimal laboratory growth conditions, the absence of the 14-kDa fragment in topoisomerase I thus affected the function of topoisomerase I in stress response significantly.



View larger version (9K):
[in this window]
[in a new window]
 
FIG. 6.
Complementation of E. coli RFM475 ({Delta}topA) for survival after NEM treatment by topoisomerase I or its truncated forms. The survival rate of RFM475 or its transformants was normalized against the survival rate of the topA+ isogenic strain RFM445 in the same experiment. The data represents the average of three independent experiments.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The results presented here support a role of the C-terminal zinc ribbon domains in E. coli DNA topoisomerase I for interacting with the {beta}' subunit of RNA polymerase, so that negative DNA supercoiling formed during transcription can be removed immediately. The rapid removal of transcription-driven negative supercoils would prevent the formation of R-loops (8, 9). This suppression of R-loops during transcription has been proposed to be an essential function for E. coli DNA topoisomerase I (24).

Sequence analysis shows that the number of zinc ribbon domains in type IA DNA topoisomerases found in different organisms varies from zero to five (20). If present, these zinc ribbon domains can potentially interact with RNA polymerase in these organisms during transcription. Other DNA topoisomerases have also been shown previously to be involved directly in transcription. Human topoisomerase I, a type IB topoisomerase, has been shown to be a cofactor of RNA polymerase II transcription (25, 26), whereas topoisomerase II{alpha} is required for RNA polymerase II transcription on chromatin templates (27).

We have observed previously that a recombinant plasmid expressing the 14-kDa C-terminal domain of E. coli DNA topoisomerase I under the T7 promoter was unstable in E. coli BL21DE3 (12). Attempts to construct a recombinant plasmid expressing the 14-kDa C-terminal domain as a MBP-fusion protein in pMal-c2X were unsuccessful. The results showing the interference of E. coli DNA topoisomerase I function during transcription by the 14-kDa C-terminal domain would account for the instability of these recombinant plasmids. It may be possible for topoisomerase I function or DNA supercoiling to be modulated via targeting of the protein-protein interactions between topoisomerase I and its partners in E. coli.

Besides Tn5 transposase and RNA polymerase in E. coli, cellular proteins in other organisms may also interact with type IA topoisomerases. This is particularly intriguing for mammalian type IA topoisomerases. There are two type IA topoisomerases (TOP3{alpha} and TOP3{beta}) present in both human and mouse (2832) with four zinc ribbon domains present in each of these enzymes (21). Human TOP3{alpha} has been shown to interact with the Bloom Syndrome helicase, BLM (33, 34), whereas both TOP3{alpha} and TOP3{beta} interact with human RecQ5{beta} helicase (35). There is evidence that interaction between Bloom Syndrome helicase and human TOP3{alpha} is important for genomic stability (36). The domains in TOP3{alpha} and TOP3{beta} responsible for the interactions with the RecQ family of helicases have not been identified experimentally. Multiple transcripts from alternative splicing with tissue specific expression pattern give rise to variant forms of TOP3{beta} that have different numbers of zinc ribbon domains (31). This can affect the interaction of TOP3{beta} with other cellular proteins. The potential involvement of these zinc ribbon domains in protein-protein interactions may play the important role of directing different forms of mammalian type IA topoisomerases to complexes involved in replication, transcription, recombination, or DNA repair.


    FOOTNOTES
 
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} Present address: Dept. of Physiology, 194 Xuefu Rd., Harbin Medical University, Harbin 150086, China. Back

§ Present address: The Inst. for Genomic Research, 9712 Medical Center Dr., Rockville, MD 20850. Back

Supported by National Institutes of Health Grant GM54226. To whom correspondence should be addressed. Tel.: 914-594-4061; Fax: 914-594-4058; E-mail: yuk-ching_tse-dinh{at}nymc.edu.

1 The abbreviations used are: MBP, maltose-binding protein; DIG, digoxigenin; NEM, N-ethylmaleimide. Back


    ACKNOWLEDGMENTS
 
We thank Richard Burgess for suggestions on the RNA polymerase affinity chromatography, Victor Fried for suggestions on the {beta}' subunit identification, and Marc Drolet for helpful discussions.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Champoux, J. J. (2001) Annu. Rev. Biochem. 70, 369–413[CrossRef][Medline] [Order article via Infotrieve]
  2. Wang, J. C. (1996) Annu. Rev. Biochem. 65, 635–692[CrossRef][Medline] [Order article via Infotrieve]
  3. Tse-Dinh, Y.-C. (1998) Biochim. Biophys. Acta 1400, 19–27[Medline] [Order article via Infotrieve]
  4. Drlica, K. (1992) Mol. Microbiol. 6, 415–433
  5. Zechiedrich, E. L., Khodursky, A. B., Bachellier, S., Schneider, R., Chen, D., Lilley, D. M., and Cozzarelli, N. R. (2000) J. Biol. Chem. 275, 8103–8113[Abstract/Free Full Text]
  6. Liu, L. F., and Wang, J. C. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7024–7027[Abstract/Free Full Text]
  7. Tsao, Y.-P., Wu, H.-Y., and Liu, L. F. (1989) Cell 56, 111–118[CrossRef][Medline] [Order article via Infotrieve]
  8. Drolet, M., Phoenix, P., Menzel, R., Massé, E., Liu, L. F., and Crouch, R. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3526–3530[Abstract/Free Full Text]
  9. Massé, E., and Drolet, M. (1999) J. Biol. Chem. 274, 16659–16664[Abstract/Free Full Text]
  10. Yigit, H., and Reznikoff, W. S. (1999) J. Bacteriol. 181, 3185–3192[Abstract/Free Full Text]
  11. Zhu, C.-X., and Tse-Dinh, Y.-C. (1999) in Methods in Molecular Biology (Bjornsti, M.-A., and Osheroff, N., eds) pp. 145–151, Humana Press, Totowa, NJ
  12. Zhu, C.-X., Samuel, M., Pound, A., Ahumada, A., and Tse-Dinh, Y.-C. (1995) Biochem. Mol. Biol. Int. 35, 375–385[Medline] [Order article via Infotrieve]
  13. Ahumada, A., and Tse-Dinh, Y.-C. (1998) Biochem. Biophys. Res. Commun. 251, 509–514[CrossRef][Medline] [Order article via Infotrieve]
  14. Ahumada, A., and Tse-Dinh, Y.-C. (2002) BMC Biochemistry http://www.biomedcentral.com/1471-2091/3/13
  15. Thompson, N. E., Hager, D. A., and Burgess, R. R. (1992) Biochemistry 31, 7003–7008[CrossRef][Medline] [Order article via Infotrieve]
  16. Leng, F., and McMacken, R. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 9139–9144[Abstract/Free Full Text]
  17. Drolet, M., Bi, X., and Liu, L. F. (1994) J. Biol. Chem. 269, 2068–2074[Abstract/Free Full Text]
  18. Zumstein, L., and Wang, J. C. (1986) J. Mol. Biol. 191, 333–340[CrossRef][Medline] [Order article via Infotrieve]
  19. Beran-Steed, R. K., and Tse-Dinh, Y.-C. (1989) Proteins Struct. Funct. Genet. 6, 249–258[CrossRef][Medline] [Order article via Infotrieve]
  20. Tse-Dinh, Y.-C. (2000) J. Bacteriol. 182, 829–832[Abstract/Free Full Text]
  21. Grishin, N. V. (2000) J. Mol. Biol. 299, 1165–1177[CrossRef][Medline] [Order article via Infotrieve]
  22. Schleif, R. (1992) Annu. Rev. Biochem. 61, 199–223[CrossRef][Medline] [Order article via Infotrieve]
  23. Wang, Y., Lynch, A. S., Chen, S.-J., and Wang, J. C. (2002) J. Biol. Chem. 277, 1203–1209[Abstract/Free Full Text]
  24. Massé, E., and Drolet, M. (1999) J. Biol. Chem. 274, 16654–16658[Abstract/Free Full Text]
  25. Merino, A., Madden, K. R., Lane, W. S., Champoux, J. J., and Reinberg, D. (1993) Nature 365, 227–232[CrossRef][Medline] [Order article via Infotrieve]
  26. Kretzachmar, M., Meisterernst, M., and Roeder, R. G. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11508–11512[Abstract/Free Full Text]
  27. Mondal, N., and Parvin, J. D. (2001) Nature 413, 435–438[CrossRef][Medline] [Order article via Infotrieve]
  28. Hanai, R., Caron, P. R., and Wang, J. C. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 3653–3657[Abstract/Free Full Text]
  29. Li, W., and Wang, J. C. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 1010–1013[Abstract/Free Full Text]
  30. Kawasaki, K., Minoshima, S., Nakato, E., Shibuya, K., Shintani, A., Schmeits, J. L., Wang, J., and Shimizu, N. (1997) Genome Res. 7, 250–261[Abstract/Free Full Text]
  31. Ng, S.-W., Liu Y., Hasselblatt, K. T., Mok, S. C., and Berkowitz, R. S. (1999) Nucleic Acids Res. 27, 993–1000[Abstract/Free Full Text]
  32. Seki, T., Seki, M., Onodera, R., Katada, T., and Enomoto, T. (1998) J. Biol. Chem. 273, 28553–28556[Abstract/Free Full Text]
  33. Wu, L., Davies, S. L., North, P. S., Goulaouic, H., Riou, J.-F., Turley, H., Gatter, K. C., and Hickson, I. D. (2000) J. Biol. Chem. 275, 9636–9644[Abstract/Free Full Text]
  34. Johnson, F. B., Lombard, D. B., Neff, N. F., Mastrangelo, M.-A., Dewolf, W., Ellis, N. A., Marciniak, R. A., Yin, Y., Jaenisch, R., and Guarente, L. (2000) Cancer Res. 60, 1162–1167[Abstract/Free Full Text]
  35. Shimamoto, A., Nishikawa, K., Kitao, S., and Furuichi, Y. (2000) Nucleic Acids Res. 28, 1647–1655[Abstract/Free Full Text]
  36. Hu, P., Beresten, S. F., van Brabant, A. J., Ye, T. Z., Pandolfi, P. P., Johnson, F. B., Guarente, L., and Ellis, N. A. (2001) Hum. Mol. Genet. 10, 1287–1298[Abstract/Free Full Text]
  37. Zhu, C.-X., and Tse-Dinh, Y.-C. (2000) J. Biol. Chem. 275, 5318–5322[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Microbiol. Mol. Biol. Rev.Home page
E. Guisbert, T. Yura, V. A. Rhodius, and C. A. Gross
Convergence of Molecular, Modeling, and Systems Approaches for an Understanding of the Escherichia coli Heat Shock Response
Microbiol. Mol. Biol. Rev., September 1, 2008; 72(3): 545 - 554.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. Nonaka, M. Blankschien, C. Herman, C. A. Gross, and V. A. Rhodius
Regulon and promoter analysis of the E. coli heat-shock factor, {sigma}32, reveals a multifaceted cellular response to heat stress.
Genes & Dev., July 1, 2006; 20(13): 1776 - 1789.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Plank, S. H. Chu, J. R. Pohlhaus, T. Wilson-Sali, and T.-s. Hsieh
Drosophila melanogaster Topoisomerase III{alpha} Preferentially Relaxes a Positively or Negatively Supercoiled Bubble Substrate and Is Essential during Development
J. Biol. Chem., February 4, 2005; 280(5): 3564 - 3573.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. A. Stupina and J. C. Wang
DNA axial rotation and the merge of oppositely supercoiled DNA domains in Escherichia coli: Effects of DNA bends
PNAS, June 8, 2004; 101(23): 8608 - 8613.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/33/30705    most recent
M303403200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, B.
Right arrow Articles by Tse-Dinh, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, B.
Right arrow Articles by Tse-Dinh, Y.-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.